The NPY immunoreactivity in the CSF was reported to be higher in migraineurs during the attacks than in controls [158], whereas another research group did not observe an NPY immunoreactivity elevation in the suboccipital CSF plasma during attacks and attack-free periods of patients with migraine without aura [157]. This evidence concerns the gene NPY and migraine disorder.